Albertsons Companies, Inc. (ACI) Q1 2025 Earnings Call Transcript

Albertsons (ACI) reported Q1 2025 identical sales growth of 2.8%, driven by robust 25% digital and 20% pharmacy growth, with adjusted EBITDA at $1.11 billion and EPS at $0.55. Gross margin declined 85 basis points, primarily due to strategic investments in customer value and a mix shift towards lower-margin digital and pharmacy businesses, partially offset by productivity gains and SG&A leverage. The company raised its full-year identical sales growth outlook to 2.0-2.75% but maintained unchanged Adjusted EBITDA and EPS guidance, reflecting continued investment in its digital platforms, pharmacy, and customer value proposition, alongside ongoing labor negotiations. Management highlighted a focus on driving grocery unit growth through price investments and expects productivity initiatives, including national buying and technology modernization, to fuel future growth and align with its long-term algorithm of 2%+ identical sales and higher EBITDA growth by fiscal 2026.

Analysis

Albertsons (ACI) reported a solid Q1 2025 top-line performance with identical sales growth of 2.8%, exceeding the high end of its prior guidance. This growth was disproportionately driven by a 25% increase in digital sales, which now constitute 9% of grocery revenue, and a 20% surge in the pharmacy business. However, this mix shift, combined with deliberate investments in its customer value proposition, led to an 85-basis-point contraction in gross margin (ex-fuel/LIFO) and a decline in adjusted EBITDA to $1.11 billion from $1.18 billion year-over-year. Management has updated its full-year 2025 outlook by raising identical sales guidance to a range of 2.0% to 2.75%, yet maintained its adjusted EBITDA and EPS forecasts. This implies an acceptance of continued margin pressure in the near term to secure market share and drive a sequential improvement in grocery unit volumes, a key strategic priority. The company is funding these investments through a long-term productivity program targeting $1.5 billion in savings through fiscal 2027, with benefits from initiatives like national buying expected to materialize in the second half of the year. Capital returns remain robust, with $401 million returned to shareholders in Q1 via dividends and buybacks, signaling confidence in the long-term strategy.

Key Decisions for Investors

• Investors should recognize the updated guidance confirms a strategy of sacrificing near-term profitability for market share, as the higher identical sales growth is driven by lower-margin pharmacy and digital channels without an accompanying lift to EBITDA forecasts.
• Monitor the trajectory of grocery unit volumes and gross margin rates in the coming quarters, as sustained improvement in units is critical to validate the price investment strategy, while margin performance will signal the effectiveness of productivity initiatives.
• The investment thesis now hinges on management's execution of its long-term growth algorithm for fiscal 2026, which is predicated on converting current customer acquisition and top-line momentum into profitable EBITDA growth.
• Consider the ongoing labor negotiations covering 120,000 associates as a potential SG&A headwind, although management states current expectations are baked into guidance.